147 related articles for article (PubMed ID: 11220949)
1. [Acridonacetic acid: pharmacological properties and clinical use].
Kovalenko AL; Romantsev MG; Ershov FI
Zh Mikrobiol Epidemiol Immunobiol; 2000; (5):103-8. PubMed ID: 11220949
[TBL] [Abstract][Full Text] [Related]
2. [Experimental and clinicolaboratory evaluation of complex therapy efficacy in arboviral infections].
Romantsov MG; Galimzianov KhM; Lokteva OM; Kovalenko AL; Stepanov AV
Antibiot Khimioter; 2012; 57(7-8):12-22. PubMed ID: 23350190
[TBL] [Abstract][Full Text] [Related]
3. [Cycloferon: mechanism of action, functions and application].
Bazhanova ED
Eksp Klin Farmakol; 2012; 75(7):40-4. PubMed ID: 23025052
[TBL] [Abstract][Full Text] [Related]
4. [Antiviral properties of polynucleotides not associated with interferon induction].
Shved AD
Mikrobiol Zh (1978); 1982; 44(3):75-85. PubMed ID: 6181384
[No Abstract] [Full Text] [Related]
5. [Effect of cycloferon on dissemination of Lewis lung carcinoma in mice and rhabdomyosarcoma ra-23 in rats].
Zabezhinskii MA; Kovalenko AL; Kvetnoi IM; Iuzhakov VV; Popuchiev VV; Bakhtin IuB; Kaminskaia EV; Proshin SN; Popovich IG; Zaripova EA; Anisimov VN
Vopr Onkol; 1999; 45(6):650-4. PubMed ID: 10703515
[TBL] [Abstract][Full Text] [Related]
6. [Cytokinin inducing and antiviral activity of cycloferon on experimental herpetic infection].
Zmushko EI; Mitin IuA; Katsalukha VV; Sviridov LP; Nikolaev VP; Starenchenko VV
Zh Mikrobiol Epidemiol Immunobiol; 2003; (4):105-7. PubMed ID: 12966893
[TBL] [Abstract][Full Text] [Related]
7. [Effectiveness of cycloferon in treating virus-associated inflammatory gynecologic diseases].
Ospel'nikova TP; Grigorian SS; Evseev AA; Besaeva TP; Denisova EN; Kovalenko AL; Ershov FI
Vopr Virusol; 1999; 44(3):130-3. PubMed ID: 10392438
[TBL] [Abstract][Full Text] [Related]
8. [The therapeutic efficacy of cycloferon and the pharmacological activity of interferon inducers].
Romantsov MG; Ershov FI; Kovalenko AL; Belova OG
Ter Arkh; 2014; 86(1):83-8. PubMed ID: 24754075
[TBL] [Abstract][Full Text] [Related]
9. [Efficiency of using cycloferon as part of combined therapy for chronic hepatitis C (a review of multicenter clinical trials)].
Sologub TV; Romantsev MG; Shul'diakov AA; Lin'kova IuN; Radchenko VG; Kovalenko AL
Ter Arkh; 2010; 82(10):78-81. PubMed ID: 21341470
[TBL] [Abstract][Full Text] [Related]
10. [The medical significance of interferons and their inducers].
Ershov FI
Vestn Ross Akad Med Nauk; 2004; (2):9-13. PubMed ID: 15101201
[TBL] [Abstract][Full Text] [Related]
11. Interferon induction and suppression of solid tumor growth in rats by tilorone hydrochloride.
Rhoads AR; West WL; Morris HP
Res Commun Chem Pathol Pharmacol; 1973 Sep; 6(2):741-50. PubMed ID: 4356214
[No Abstract] [Full Text] [Related]
12. [Problems in treating influenza and acute respiratory infection in children].
Romantsov MG; Ershov FI; Kovalenko AL
Eksp Klin Farmakol; 2011; 74(6):41-5. PubMed ID: 21870775
[TBL] [Abstract][Full Text] [Related]
13. Antiviral activity of 10-carboxymethyl-9-acridanone.
Kramer MJ; Cleeland R; Grunberg E
Antimicrob Agents Chemother; 1976 Feb; 9(2):233-8. PubMed ID: 1267425
[TBL] [Abstract][Full Text] [Related]
14. [Cycloferon and management of herpes virus infection].
Alimbarova LM
Antibiot Khimioter; 2014; 59(3-4):22-9. PubMed ID: 25300118
[TBL] [Abstract][Full Text] [Related]
15. [Individual changes of gene expression in the interferon system in human blood cells due to amixin and cycloferon].
Sokolova TM; Uryvaev LV; Tazulakhova EB; Ershov FI; Malyshenkova IK; Didkovskiĭ NA
Vopr Virusol; 2005; 50(2):32-6. PubMed ID: 15881395
[TBL] [Abstract][Full Text] [Related]
16. [Effect of virazole on the antiviral activity of poly(G) X poly(C) and other polyribonucleotide interferonogens].
Vil'ner LM; Lashkevich VA
Antibiotiki; 1984 Jun; 29(6):450-3. PubMed ID: 6089650
[TBL] [Abstract][Full Text] [Related]
17. [Role of cycloferon and interferon-alphain apoptosis regulation in neuroendocrinal system on aging].
Bazhanova ED
Eksp Klin Farmakol; 2012; 75(10):42-6. PubMed ID: 23240158
[TBL] [Abstract][Full Text] [Related]
18. [Influence of cycloferon on the biological properties of bacterial intracellular pathogens].
Bukharin OV; Kirillov DA; Sheenkov NV; Kirillov VA
Zh Mikrobiol Epidemiol Immunobiol; 2005; (3):8-10. PubMed ID: 16028504
[TBL] [Abstract][Full Text] [Related]
19. [Characteristics of immune response to etiotropic and pathogenetic therapy in children with chronic hepatitis C].
Vasil'eva DK; Goriacheva LG; Monakhova NE
Eksp Klin Farmakol; 2011; 74(12):33-5. PubMed ID: 22379880
[TBL] [Abstract][Full Text] [Related]
20. [Application of immunospecific drug in the treatment of rotavirus gastroenteritis in children].
Gordeets AV; Piskunova SL; Beniova SN; Chernikova AA; Zhidkov EM
Eksp Klin Farmakol; 2013; 76(2):17-9. PubMed ID: 23631278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
